| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2a96305fda863558d903e4c8a61cd03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09471f9aef47e3123d83d67b6bcddb28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-03 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_678348db773661a0334b60aacf85e303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_214df3c76e5a468f601f35218286dc0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0311182409ce91c74a90b04f3c112a27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4cb12c5802c001ccb18617670ee522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f892553f1885f3fb210b357dfc86faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9099df70a887eea193a13b148d6e764b |
| publicationDate |
2011-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1353684-B1 |
| titleOfInvention |
Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia |
| abstract |
The invention relates to a method which reduces or prevents lesions to cerebral tissues after ischaemia or brain/cerebral traumas, involving the separate or combined administration and effect of enzyme inhibitors of alanyl-aminopeptidase (APN) and dipeptidylpeptidase IV (DP IV) or enzymes having the same similar substrate specificity. The invention demonstrates that in order to prevent or treat the above-mentioned indications, the separate or combined application of inhibitors of the above-mentioned enzymes or corresponding preparations and forms of administration are suitable. |
| priorityDate |
2001-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |